Sullivan KE. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Immunol Rev. 2019;287:186–201. https://doi.org/10.1111/imr.12701.

Article  CAS  PubMed  Google Scholar 

Kruszka P, Addissie YA, McGinn DE, Porras AR, Biggs E, Share M, et al. 22q11.2 Deletion Syndrome in Diverse Populations. Am J Med Genet A. 2017;173:879–88. https://doi.org/10.1002/ajmg.a.38199.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Repetto GM, Guzmán ML, Puga A, Calderón JF, Astete CP, Aracena M, et al. Clinical features of chromosome 22q11.2 microdeletion syndrome in 208 Chilean patients. Clin Genet. 2009;76:465–70. https://doi.org/10.1111/j.1399-0004.2009.01234.x.

Article  CAS  PubMed  Google Scholar 

Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Pediatric AIDS Clinical Trials Group, Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973–80. https://doi.org/10.1016/j.jaci.2003.07.003.

Article  PubMed  Google Scholar 

Óskarsdóttir S, Boot E, Crowley TB, Loo JCY, Arganbright JM, Armando M, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023;25:100338. https://doi.org/10.1016/j.gim.2022.11.006.

Article  CAS  PubMed  Google Scholar 

Giardino G, Radwan N, Koletsi P, Morrogh DM, Adams S, Ip W, Worth A, et al. Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center. Blood. 2019;133:2586–96. https://doi.org/10.1182/blood.2018885244.

Article  CAS  PubMed  Google Scholar 

Goldmuntz E. 22q11.2 deletion syndrome and congenital heart disease. Am J Med Genet C Semin Med Genet. 2020;184:64–72. https://doi.org/10.1002/ajmg.c.31774.

Article  PubMed  Google Scholar 

Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003;112:101–7. https://doi.org/10.1542/peds.112.1.101.

Article  PubMed  Google Scholar 

Cheung ENM, George SR, Costain GA, Andrade DM, Chow EWC, Silversides CK, et al. Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome. Clin Endocrinol (Oxf). 2014;81:190–6. https://doi.org/10.1111/cen.12466.

Article  CAS  PubMed  Google Scholar 

O’Byrne ML, Yang W, Mercer-Rosa L, Parnell AS, Oster ME, Levenbrown Y, Tanel RE, et al. 22q11.2 Deletion syndrome is associated with increased perioperative events and more complicated postoperative course in infants undergoing infant operative correction of truncus arteriosus communis or interrupted aortic arch. J Thorac Cardiovasc Surg. 2014;148:1597–605. https://doi.org/10.1016/j.jtcvs.2014.02.011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cuturilo G, Drakulic D, Jovanovic I, Ilic S, Kalanj J, Vulicevic I, et al. The impact of 22q11.2 microdeletion on cardiac surgery postoperative outcome. Pediatr Cardiol. 2017;38:1680–5. https://doi.org/10.1007/s00246-017-1713-7.

Article  PubMed  Google Scholar 

Jackson O, Crowley TB, Sharkus R, Smith R, Jeong S, Solot C, et al. Palatal evaluation and treatment in 22q11.2 deletion syndrome. Am J Med Genet A. 2019;179:1184–95. https://doi.org/10.1002/ajmg.a.61152.

Article  CAS  PubMed  Google Scholar 

Morsheimer M, Brown Whitehorn TF, Heimall J, Sullivan KE. The immune deficiency of chromosome 22q11.2 deletion syndrome. Am J Med Genet A. 2017;173:2366–72. https://doi.org/10.1002/ajmg.a.38319.

Article  CAS  PubMed  Google Scholar 

Campbell IM, Sheppard SE, Crowley TB, McGinn DE, Bailey A, McGinn MJ, et al. What is new with 22q? An update from the 22q and You Center at the Children’s Hospital of Philadelphia. Am J Med Genet A. 2018;176:2058–69. https://doi.org/10.1002/ajmg.a.40637.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr. 2001;139:715–23. https://doi.org/10.1067/mpd.2001.118534.

Article  CAS  PubMed  Google Scholar 

Kreins AY, Dhalla F, Flinn AM, Howley E, Ekwall O, Villa A, et al. European society for immunodeficiencies guidelines for the management of patients with congenital athymia. J Allergy Clin Immunol. 2024;154:1391–408. https://doi.org/10.1016/j.jaci.2024.07.031.

Article  PubMed  Google Scholar 

Gennery AR, Barge D, O’Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child. 2002;86:422–5. https://doi.org/10.1136/adc.86.6.422.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Derfalvi B, Maurer K, McDonald McGinn DM, Zackai E, Meng W, Luning Prak ET, et al. B cell development in chromosome 22q11.2 deletion syndrome. Clin Immunol Orlando Fla. 2016;163:1–9. https://doi.org/10.1016/j.clim.2015.12.004.

Article  CAS  Google Scholar 

Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Pediatrics. 2003;112: e325. https://doi.org/10.1542/peds.112.4.e325.

Article  PubMed  Google Scholar 

Berkhout A, Preece K, Varghese V, Prasad V, Heussler H, Clark J, et al. Optimising immunisation in children with 22q11 microdeletion. Ther Adv Vaccines Immunother. 2020;8: 2515135520957139. https://doi.org/10.1177/2515135520957139.

Article  PubMed  PubMed Central  Google Scholar 

Moylett EH, Wasan AN, Noroski LM, Shearer WT. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin Immunol Orlando Fla. 2004;112:106–12. https://doi.org/10.1016/j.clim.2004.02.008.

Article  CAS  Google Scholar 

Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr. 2003;143:277–8. https://doi.org/10.1067/S0022-3476(03)00248-8.

Article  PubMed  Google Scholar